Live Breaking News & Updates on Lenz Therapeutics|Page 2
Stay updated with breaking news from Lenz therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) Director Ra Capital Management, L.P. purchased 998,009 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was acquired at an average cost of $15.03 per share, for a total transaction of $15,000,075.27. Following the completion of the acquisition, the director now […] ....
Getting a Next-Generation Genome Editing Therapy for Sickle Cell Disease Back on Track globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
For biotech dealmakers, it's everything, everywhere all at once fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Kamau Therapeutics Emerges from Stealth with Graphite Bio's Gene-Editing Portfolio globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Sanofi explores consumer health spinoff; FTC warns trade groups, influencers about social media posts promoting aspartame; Graphite Bio agrees to merge with Lenz Therapeutics. ....